United StatesOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 3,370 out of 157,499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 395,438 | 330,607 |
| Total Cites | 468 | 559 |
| H-index | 11 | 12 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 33 | 53 |
| Number of Single+First+Last Authored Papers | 19 | 19 |
| Total Cites to Single+First+Last Authored Papers | 54 | 82 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 416 | 437 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.28 |
| Self-Citation Percentage |
16.28%
|
|
ChinaOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 4,285 out of 140,593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 475,726 | 331,023 |
| Total Cites | 311 | 402 |
| H-index | 8 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 47 | 73 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 53 | 83 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 255 | 274 |
| Ratio of Total Citations to Distinct Citing Papers | 1.22 | 1.47 |
| Self-Citation Percentage |
22.64%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 3,501 out of 134,745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 399,637 | 325,353 |
| Total Cites | 279 | 344 |
| H-index | 8 | 9 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 59 | 87 |
| Number of Single+First+Last Authored Papers | 11 | 11 |
| Total Cites to Single+First+Last Authored Papers | 59 | 87 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 225 | 238 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.45 |
| Self-Citation Percentage |
18.90%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Nanoscience & Nanotechnology
Rank in SubField 1: 3,097 out of 131,063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 358,616 | 302,935 |
| Total Cites | 451 | 536 |
| H-index | 11 | 13 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 91 | 133 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 91 | 133 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 358 | 374 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.43 |
| Self-Citation Percentage |
15.86%
|
|
Related Profiles
Top 2% Scientists by Country
236,132 scientists from 167 countries on the 2025 single-year list.
China31,697 scientists, 2nd in the world
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.